Therapeutic Area | MeSH |
---|---|
nutritional and metabolic diseases | D009750 |
endocrine system diseases | D004700 |
Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Fiasp | insulin aspart | Novo Nordisk | N-208751 RX | 2017-09-29 | 4 products |
Novolog | insulin aspart | Novo Nordisk | N-20986 RX | 2000-06-07 | 3 products |
Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Novolog Mix 70/30 | insulin aspart protamine and insulin aspart | Novo Nordisk | N-21172 RX | 2001-11-01 | 2 products |
Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Ryzodeg 70/30 | insulin degludec and insulin aspart | Novo Nordisk | N-203313 DISCN | 2015-09-25 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
.insulin aspart protamine and insulin aspart | Biologic Licensing Application | 2024-02-22 |
.insulin aspart protamine and insulin aspart insulin aspart protamine and insulin aspart | Biologic Licensing Application | 2019-11-15 |
adderall | New Drug Application | 2025-03-13 |
adderall xr | New Drug Application | 2010-03-29 |
aminosyn ii | New Drug Application | 2022-05-04 |
aminosyn-pf | New Drug Application | 2022-07-21 |
chromagen | unapproved drug other | 2024-01-23 |
clinisol | ANDA | 2018-06-01 |
dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate | ANDA | 2023-10-20 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate | ANDA | 2025-03-17 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
type 2 diabetes mellitus | EFO_0001360 | D003924 | E11 |
type 1 diabetes mellitus | EFO_0001359 | D003922 | E10 |
hyperglycemia | — | D006943 | R73.9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 6 | — | 6 | 6 | — | 18 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | — | 3 | 7 | — | 11 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 4 | — | 3 | 3 | 1 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyperglycemia | D006943 | — | R73.9 | — | — | — | — | 1 | 1 |
Drug common name | Insulin aspart |
INN | insulin aspart |
Description | Insulin aspart |
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201496 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB01306 |
UNII ID | D933668QVX (ChemIDplus, GSRS) |